Energy & Commerce’s Health Counsel Cohen Is Long-Time Industry Advocate
This article was originally published in The Gray Sheet
Executive Summary
Howard Cohen is returning to the House Energy and Commerce Committee as chief health counsel after a decade as a Washington lobbyist, where his clients included biopharmaceutical and medical device makers as well as private insurance firms, hospitals and other health care providers.
You may also be interested in...
Device Industry Friend To Head Energy And Commerce Panel
Michigan Republican Fred Upton, the incoming House Energy and Commerce Committee Chairman, is well-informed on health care and medical device policy issues, and likely will be an industry-friendly force in the 112th Congress, industry reps say.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.